“2020 is a different year”: A report from our virtual COVID-19 Vaccine BioBreakfast with Dr Rob Grenfell
24 March 2020 In just a few short months, COVID-19 has completely changed the world. From the initial novel Coronavirus outbreak in Wuhan to Europe becoming the new epicentre of infection, the world is at the mercy of…
BioMelbourne Network’s response to COVID-19 – Message from the Chair
17 March 2020 As a sector, we are experiencing unprecedented disruption as a result of the fast moving and evolving COVID-19 situation. In line with our commitment to providing a safe environment for members, staff and the broader…
Collaborate to Innovate – Key Themes from the 8th Annual Devices + Diagnostics Lab
12 March 2020 On Thursday 5th March 2020 BioMelbourne Network held their 8th Annual Devices + Diagnostics Lab, addressing the theme of Manufacturing, Markets and Minefields in the medical technology sector. Over 160 industry professionals spent the day…
Message from the Chair of BioMelbourne Network
18 February 2020 The Board of BioMelbourne Network advises members and stakeholders that our Chief Executive Officer, Dr Julie-Anne White, has given notice of her resignation. Julie will assist in the transition and hand-over to an interim CEO,…
Taskforce To Help Shape Victoria’s Innovation Agenda
13 February 2020 Taskforce To Help Shape Victoria’s Innovation Agenda Minister for Jobs, Innovation and Trade The Andrews Labor Government is bolstering Victoria’s position as a leading destination for tech and innovation by bringing together startups, universities, businesses…
BioMelbourne Network Actions on the R&D Tax Incentive
8 February 2020 As you are aware, the Treasury Laws Amendment (Research and Development Tax Incentive) Bill 2019 (the Bill) was introduced to the House of Representatives on 5 December 2019. It will return to the House on…
Digital Health Revolution
4 December 2019 Research Australia and the BioMelbourne Network are championing a Digital Health Revolution for Australia. Embracing digital technologies provides the opportunity to improve health outcomes, promote wellbeing and a sustainable health system, but it is going…
Expression of Interest – Nanomedicine Working Group
28 November 2019 The nanomedicine working group is a cross-functional collaborative designed to support Australia in defining a regulatory pathway for nanomedicines and their follow-on products, nanosimilars. The focus of the group will include approval and post approval…
New BioMelbourne Network Board Appointment – Dr Elane Zelcer
15 November 2019 The BioMelbourne Network Board was delighted to welcome Dr Elane Zelcer as new Board Director at the most recent Annual General Meeting. Dr Elane Zelcer, Director, BioConsult Pty Ltd. Dr Elane Zelcer has extensive experience…
BioMelbourne Network is pleased to announce a collaboration with Australia China Health Accelerator
13 November 2019 UprAsia Founder Education Program – Elevate your startup’s Asia readiness About UprAsia Are you the founder or executive of a health technology startup or SME who recognise that Asian, especially Chinese markets, offer vast opportunity but…
Victorian healthtech startups go-to-market in the USA
30 October 2019 Five Victorian medical device startups are better placed to take on the world after visiting Minnesota for the final Masterclass of BioMelbourne Network’s 2019 Healthtech Reimbursement program. Go-To-Market in the USA was a three-day experiential…
Tim Oldham Appointed as Chief Executive Officer of AdAlta Ltd
9.10.2019 MELBOURNE Australia: The Board of AdAlta Limited (ASX:1AD), is pleased to announce the appointment of experienced global pharmaceutical executive Dr Tim Oldham as Chief Executive Officer and Managing Director. Dr Oldham has extensive skills and expertise over…
